PT - JOURNAL ARTICLE AU - Klöbl, Manfred AU - Reed, Murray Bruce AU - Handschuh, Patricia AU - Kaufmann, Ulrike AU - Konadu, Melisande Elisabeth AU - Ritter, Vera AU - Spurny-Dworak, Benjamin AU - Kranz, Georg S. AU - Lanzenberger, Rupert AU - Spies, Marie TI - Gender dysphoria and sexual euphoria – A Bayesian perspective on the influence of gender-affirming hormone therapy on sexual arousal AID - 10.1101/2021.11.22.21266679 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.22.21266679 4099 - http://medrxiv.org/content/early/2021/11/23/2021.11.22.21266679.short 4100 - http://medrxiv.org/content/early/2021/11/23/2021.11.22.21266679.full AB - While the concept of sexual orientation is more clearly defined in cisgender, this is less so in transgender individuals. Both experienced gender and sex hormones have a relation to sexual preferences, arousal in response to erotic stimuli, and thus sexual orientation. In transgender individuals sexual orientation occasionally changes before or during transition, which may involve gender-affirming hormone therapy. Using functional magnetic resonance imaging, we investigated whether the neuronal and behavioral patterns of sexual arousal in transgender individuals moved from the given (before) to their chosen gender after 4.5 months of hormone therapy. To this aim, trans women and men as well as age-matched cisgender controls rated visual stimuli showing heterosexual, lesbian or gay intercourse for subjective sexual arousal. Utilizing a Bayesian framework allowed us to incorporate behavioral findings in cisgender individuals of different sexual orientations. The hypothesized changes in response patterns could indeed be observed in the behavioral responses to the single but not the differentiation between stimulus categories with the strongest results for trans men and lesbian scenes. Activation of the ventral striatum supported our hypothesis only for lesbian scenes in trans women. This prominent role of lesbian stimuli might be explained by their differential responses in cis women and men. We show that correlates of sexual arousal in transgender individuals might change in direction of the chosen gender. Future investigations longer into transition might resolve the discrepancy on behavioral and neuronal levels.Competing Interest StatementRupert Lanzenberger received travel grants and/or conference speaker honoraria within the last three years from Bruker BioSpin MR and Heel, and has served as a consultant for Ono Pharmaceutical. He received investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. Marie Spies received travel grants from Janssen, AOP Orphan Pharmaceuticals; Lecture Honoraria: Heel, Janssen and Austroplant. She further spoke at a workshop organized by Eli Lilly.Clinical TrialNCT02715232Funding StatementThis research was funded as whole or in part by the Austrian Science Fund (FWF) [KLI 504 and KLI 516 PI: Rupert Lanzenberger], a Brain and Behavior Research Foundation (formerly NARSAD) Young Investigator grant (23741, PI: Marie Spies), the Medical Imaging Cluster of the Medical University of Vienna, and by the grant "Interdisciplinary translational brain research cluster (ITHC) with highfield MR" from the Federal Ministry of Science, Research and Economy (BMWFW), Austria. Manfred Klöbl and Murray Bruce Reed are recipients of a DOC Fellowship of the Austrian Academy of Sciences.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the institutional review board of the Medical University of Vienna (EK Nr.: 1104/2016).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to reasons of data protection, the preprocessed data is available only upon reasonable request to the corresponding author.